TY  - RPRT
TI  - NDC80 status pinpoints mitotic kinase inhibitors as emerging therapeutic options in clear cell renal cell carcinoma
AU  - Hu, C.
AU  - Lin, W.
AU  - Zhao, K.
AU  - Tian, G.
AU  - Kong, X.
AU  - Luo, G.
AU  - Wolf, D. A.
AU  - Cheng, Y.
PY  - 2023
DO  - 10.1101/2023.03.07.531634
UR  - https://www.biorxiv.org/content/10.1101/2023.03.07.531634v1
ID  - 10.1101/2023.03.07.531634
ER  -